Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Hypertrophic Cardiomyopathy Panel Invitae United States | 69 | 30 |
|
Left Ventricular Noncompaction (LVNC) Panel PreventionGenetics, part of Exact Sciences United States | 15 | 13 |
|
Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy via the TPM1 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Cardiomyopathy, dilated 1Y (sequence analysis of TPM1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Dilatative Cardiomyopathy Panel (DCM Panel) Labor Dr. Wisplinghoff Germany | 43 | 43 |
|
Genologica Medica Spain | 172 | 59 |
|
Hypertrophic Cardiomyopathy Panel, Sequencing ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 25 | 34 |
|
TPM1 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 2 | 1 |
|
Left ventricular noncompaction cardiomyopathy Asper Biogene Asper Biogene LLC Estonia | 33 | 13 |
|
Arrhythmia & Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 211 | 93 |
|
Left Ventricular Noncompaction Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 37 | 12 |
|
Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 170 | 71 |
|
Cardiomyopathy Panel, Hypertrophic CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 85 | 35 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 134 | 48 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Left ventricular noncompaction: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 15 | 9 |
|
Dilated cardiomyopathy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 45 | 35 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States | 450 | 128 |
|
Hypertrophic Cardiomyopathy NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 45 | 24 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.